FinTechFunding

BTC Health: Investee gains NEOLA distribution rights

  • BTC Health (BTC) investee BioImpact has won exclusive rights to distribute the NEOLA device in Australia, New Zealand and Singapore
  • NEOLA is a non-invasive medical device to measure volume changes and oxygen concentration in the lungs of preterm infants
  • This allows health care professionals to instantly detect complications and provide the required treatment
  • BioImpact secured the rights from GPX Medical AB, which expects to obtain CE approval for NEOLA in 2023
  • Pending CE approval, BTC Health will begin the registration process allowing NEOLA to commercially launch in Australia and New Zealand
  • BTC Health spiked over 100 per cent earlier today but is now up just 11.25 per cent to trade at 8.9 cents per share
Previous article
AccountsIQ: Raises €5.8M in Funding
Next article
Superloop: Wins $25M contract with MNF Group’s Symbio
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...